The fixed-effect model was carried out to estimate the association of GSTP1 gene polymorphism and the NAFLD risk by virtue of no heterogeneity among studies (P = .47, I2 = 0%). This evidence concerns the gene GSTP1 and metabolic dysfunction-associated steatotic liver disease.